Stefan Glombitza
Chief Executive Officer en FORMYCON AG .
Perfil
Stefan Glombitza is currently the Chief Executive Officer at Formycon AG since 2022.
Previously, he worked at Hexal AG as a Manager-Medical Affairs and at Hexal Pharmaforschung GmbH as the Head-Project Management.
Dr. Glombitza holds a doctorate degree from the University of Regensburg.
Cargos activos de Stefan Glombitza
| Empresas | Cargo | Inicio |
|---|---|---|
| FORMYCON AG | Chief Executive Officer | 01/07/2022 |
Antiguos cargos conocidos de Stefan Glombitza.
| Empresas | Cargo | Fin |
|---|---|---|
| Hexal Pharmaforschung GmbH | Corporate Officer/Principal | - |
Hexal AG
 Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Corporate Officer/Principal | - |
Formación de Stefan Glombitza.
| University of Regensburg | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| FORMYCON AG | Health Technology |
| Empresas privadas | 2 |
|---|---|
Hexal AG
Hexal AG Pharmaceuticals: MajorHealth Technology H e x a l AG develops, produces, markets and distributes modern generics and medicinal products. Its areas of emphasis are cardiovascular medicinal products, pain therapy medications and gastrointestinal products. The company was founded in April 1986 and is headquartered in Holzkirchen, Germany. | Health Technology |
| Hexal Pharmaforschung GmbH |
- Bolsa de valores
- Insiders
- Stefan Glombitza
